Frankfurt
21.01.25
14:35 Uhr
0,050 Euro
-0,010
-16,67 %
-16,67 %
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,011 | 0,061 | 21.01. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 10.01.2025 | 144 | Xetra Newsboard | Das Instrument FQ1 KYG8656L1068 TH INTL LTD DL-,0001 EQUITY wird cum Kapitalmassnahme gehandelt am 10.01.2025 und ex Kapitalmassnahme am 13.01.2025 The instrument FQ1 KYG8656L1068 TH INTL LTD DL-,0001... ► Artikel lesen | |
| 03.01. | Q-linea AB: Q-linea resolves on the terms for a rights issue of approximately SEK 225 million | 427 | GlobeNewswire (Europe) | Q-linea AB (publ) ("Q-linea" or the "Company") announces that the board of directors today has resolved on the terms for the planned rights issue of units with preferential rights for the Company's... ► Artikel lesen | |
| 05.11.24 | Q-linea AB: Interim report 1 January - 30 September 2024 | 92 | GlobeNewswire (Europe) | Growing pipeline in the US
Third quarter: 1 July - 30 September 2024Net sales amounted to SEK 0.6 million (3.0).The operating result totalled SEK -41.1 million (-48.2).The result for the period amounted... ► Artikel lesen | |
| 11.07.24 | Q-Linea AB: Interim report 1 January - 30 June 2024 | 69 | GlobeNewswire (Europe) | ASTar launches in the US market
Second quarter: 1 April-30 June 2024Net sales amounted to SEK 0.2 million (1.4).The operating result totalled SEK -65.3 million (-64.6).The result for the period amounted... ► Artikel lesen | |
| Q-LINEA Aktie jetzt für 0€ handeln | |||||
| 31.05.24 | Q-Linea AB: Interim report 1 January - 31 March 2024 | 148 | GlobeNewswire (Europe) | ASTar approved for the American market
First quarter: 1 January-31 March 2024Net sales amounted to SEK 1.5 million (0).The operating result totalled SEK -56.0 million (-62.2).The result for the period... ► Artikel lesen | |
| 29.02.24 | Q-Linea joins forces with Uniphar Logistics in Raleigh, NC | 661 | ACCESS Newswire | RALEIGH, NC / ACCESSWIRE / February 29, 2024 / Q-Linea, dedicated to advancing infectious disease diagnostics, joins forces with Uniphar Logistics here in Raleigh, North Carolina for an exciting future... ► Artikel lesen | |
| 27.02.24 | Q-Linea AB: Year-end report 1 January - 31 December 2023 | 99 | GlobeNewswire (Europe) | ASTar installed at two prominent US hospitals
Fourth quarter: 1 October-31 December 2023Net sales amounted to SEK 0.1 million (0).The operating result totalled SEK -55.4 million (-59.6).The result for... ► Artikel lesen |
7 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 36,210 | -0,47 % | Fresenius SE Aktie: Zeichen stehen auf Gewinn | Die Fresenius SE-Aktie zeigt sich am Handelstag in robuster Verfassung und verzeichnet eine positive Entwicklung im XETRA-Handel. Das Wertpapier konnte im Tagesverlauf um 0,6 Prozent zulegen und erreichte... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 44,340 | -0,36 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für FMC mit einem Kursziel von 52 Euro auf "Buy" belassen. Analyst Richard Felton nahm in einer am Montagabend vorliegenden... ► Artikel lesen | |
| SERNOVA | 0,130 | -2,91 % | Sernova (TSE:SVA) Sets New 12-Month Low - Here's What Happened | ||
| NUGEN MEDICAL DEVICES | 0,051 | +4,90 % | Unglaubliche News! Der Super-CEO der alle Türen öffnen kann! | ||
| HEALWELL AI | 1,250 | -0,79 % | HEALWELL AI schließt die Eigenkapitaltranche im Wert von 25,5 Millionen $ seiner aufgestockten Bought-Deal-Finanzierung ab | - HEALWELL hat die Eigenkapitaltranche seiner zuvor angekündigten aufgestockten Bought-Deal-Finanzierung in Höhe von 55 Millionen $ abgeschlossen und damit einen Bruttoerlös
von 25,5... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,797 | -4,44 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Full Results from Phase 2 KARISMA-Endoxifen Study Demonstrating Statistically Significant Reductions in Mammographic Breast Density | 1 MG Dose (Z)-Endoxifen Shows Potential as a Well-Tolerated, Preventative Therapy for Premenopausal Women at Risk of Developing Breast Cancer Data to be Presented in a Poster Spotlight Session During... ► Artikel lesen | |
| SPINEWAY | 0,098 | -5,12 % | Spineway wins new approvals in Vietnam and registers initial orders | Press release Ecully, December 18, 2024 - 6 p.m. Spineway wins new approvals in Vietnam and registers initial orders The Spineway Group, a specialist in innovative implants for the treatment... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,019 | -2,04 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| TEMPEST THERAPEUTICS | 0,850 | -0,12 % | Tempest Therapeutics: Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC) | BRISBANE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
| ONTRAK | 1,730 | 0,00 % | Ontrak Inc. (OTRK): AI-Powered Healthcare Solutions Under $2 Billion | ||
| VERU | 1,075 | +3,17 % | Stock Traders Purchase Large Volume of Veru Call Options (NASDAQ:VERU) | ||
| CLOVER HEALTH INVESTMENTS | 4,001 | -1,57 % | Clover Health Investments, Corp.: Clover Health Reports 27% Growth in Medicare Advantage Membership, Surpassing 100,000 Lives After Strong Annual Election Period | Robust plan benefits powered member growth, mainly driven by switchers from other plansCompany will focus on balancing profitability with strategic investments in growth and technology to take advantage... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 3,140 | 0,00 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial Officer | SEATTLE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment... ► Artikel lesen | |
| RENALYTIX | 0,152 | +16,92 % | Renalytix PLC - Foreign Private Issuer re-qualification | ||
| WESANA HEALTH | 0,006 | 0,00 % | XFRA DDX: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILWESANA HEALTH HOLD.... ► Artikel lesen |
Q-LINEA AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,010 (-16,67 %) liegt der Kurs bei 0,050 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu Q-LINEA AB finden Sie auf Wallstreet Online.
